Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Coley Pharmaceutical Group, Inc. (COLY)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/31/2008 |
4
| BATE KENNETH (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Unknown transaction of 21,834 options to buy
@ $1.15, valued at
$25.1k
|
|
01/25/2008 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Unknown transaction of 545,602 shares
@ $0 Unknown transaction of 5,240 shares
@ $0 Unknown transaction of 153,672 options to buy
@ $1.15, valued at
$176.7k
Unknown transaction of 13,646 options to buy
@ $1.15, valued at
$15.7k
Unknown transaction of 94,788 options to buy
@ $1.15, valued at
$109k
Unknown transaction of 55,000 options to buy
@ $3.13, valued at
$172.2k
|
|
01/25/2008 |
4
| Abdalian Charles H Jr (SVP, Finance and CFO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Unknown transaction of 52,402 options to buy
@ $1.15, valued at
$60.3k
Unknown transaction of 58,123 options to buy
@ $1.15, valued at
$66.8k
Unknown transaction of 40,000 options to buy
@ $3.13, valued at
$125.2k
Unknown transaction of 8,666 options to buy
@ $1.15, valued at
$10k
|
|
01/25/2008 |
4
| Massari Ferdinand E (Sr. VP of Drug Development) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Unknown transaction of 65,000 options to buy
@ $3.13, valued at
$203.5k
|
|
01/25/2008 |
4
| Bratzler Robert L (President and CEO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Unknown transaction of 308,697 shares
@ $0 Unknown transaction of 150,654 shares
@ $0 Unknown transaction of 356,987 options to buy
@ $1.15, valued at
$410.5k
Unknown transaction of 168,258 options to buy
@ $1.15, valued at
$193.5k
Unknown transaction of 70,000 options to buy
@ $3.13, valued at
$219.1k
|
|
01/25/2008 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Unknown transaction of 21,834 options to buy
@ $1.15, valued at
$25.1k
|
|
01/25/2008 |
4
| Langlois Patrick (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Unknown transaction of 21,834 options to buy
@ $1.15, valued at
$25.1k
|
|
01/25/2008 |
4
| Karobath Manfred E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Unknown transaction of 135,783 shares
@ $0 Unknown transaction of 3,753 options to buy
@ $1.15, valued at
$4.3k
Unknown transaction of 4,549 options to buy
@ $1.15, valued at
$5.2k
Unknown transaction of 11,358 options to buy
@ $5.64, valued at
$64.1k
|
|
12/14/2007 |
4
| Karobath Manfred E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Sold 27,000 shares
@ $7.93, valued at
$214.1k
|
|
09/20/2007 |
4
| Abdalian Charles H Jr (SVP, Finance and CFO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 40,000 options to buy
@ $3.13, valued at
$125.2k
|
|
09/20/2007 |
4
| Bratzler Robert L (President and CEO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 70,000 options to buy
@ $3.13, valued at
$219.1k
|
|
09/20/2007 |
4
| Massari Ferdinand E (Sr. VP of Drug Development) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 65,000 options to buy
@ $3.13, valued at
$203.5k
|
|
09/20/2007 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 55,000 options to buy
@ $3.13, valued at
$172.2k
|
|
08/29/2007 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Sold 21,070 shares
@ $1.89, valued at
$39.8k
|
|
06/15/2007 |
4
| BATE KENNETH (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 5,459 options to buy
@ $8.02, valued at
$43.8k
|
|
06/15/2007 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 5,459 options to buy
@ $8.02, valued at
$43.8k
|
|
06/15/2007 |
4
| Langlois Patrick (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 5,459 options to buy
@ $8.02, valued at
$43.8k
|
|
06/15/2007 |
4
| Karobath Manfred E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 5,459 options to buy
@ $8.02, valued at
$43.8k
|
|
05/14/2007 |
4
| THOMAS JAMES E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Bought 100,000 shares
@ $8.68, valued at
$868k
Bought 60,000 shares
@ $8.66, valued at
$519.6k
|
|
05/09/2007 |
4
| Karobath Manfred E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Bought 5,000 shares
@ $9.22, valued at
$46.1k
Bought 5,000 shares
@ $8.99, valued at
$45k
Bought 5,000 shares
@ $9, valued at
$45k
Bought 5,000 shares
@ $9.01, valued at
$45.1k
Bought 7,000 shares
@ $8.98, valued at
$62.9k
|
|
02/21/2007 |
4
| Massari Ferdinand E (SVP, Drug Dev. & CMO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 60,000 options to buy
@ $9.86, valued at
$591.6k
|
|
02/21/2007 |
4
| Krieg Arthur M (SVP, R&D, Chief Scientific Off) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 50,000 options to buy
@ $9.86, valued at
$493k
|
|
02/21/2007 |
4
| Bratzler Robert L (President & CEO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 90,000 options to buy
@ $9.86, valued at
$887.4k
|
|
02/21/2007 |
4
| Abdalian Charles H Jr (SVP Finance & CFO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 45,000 options to buy
@ $9.86, valued at
$443.7k
|
|
12/11/2006 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Sold 18,122 shares
@ $2.24, valued at
$40.6k
Gifted 300 shares
@ $0 |
|
10/16/2006 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Sold 13,210 shares
@ $1.89, valued at
$25k
|
|
06/27/2006 |
4
| Massari Ferdinand E (Sr. VP of Drug Development) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 80,000 options to buy
@ $11.37, valued at
$909.6k
|
|
06/22/2006 |
4
| BATE KENNETH (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 5,459 options to buy
@ $11.8, valued at
$64.4k
|
|
06/22/2006 |
4
| Karobath Manfred E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 5,459 options to buy
@ $11.8, valued at
$64.4k
|
|
06/22/2006 |
4
| Langlois Patrick (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 5,459 options to buy
@ $11.8, valued at
$64.4k
|
|
06/22/2006 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Granted 5,459 options to buy
@ $11.8, valued at
$64.4k
|
|
05/31/2006 |
4
| THOMAS JAMES E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Disposed of 1,000,000 shares
@ $0 Disposed of 3,680 shares
@ $0 Acquired 2,692 shares
@ $0 |
|
05/31/2006 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Disposed of 1,000,000 shares
@ $0 Disposed of 3,680 shares
@ $0 |
|
05/10/2006 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.
Txns:
| Disposed/sold 24,579 shares
@ $14.34, valued at
$352.5k
|
|
|
|
|